Literature DB >> 12420892

Generalized anxiety disorder and clinical worry episodes in young women.

J Hoyer1, E S Becker, J Margraf.   

Abstract

BACKGROUND: This article presents epidemiological data on the prevalence of DSM-IV generalized anxiety disorder (GAD) and sub-threshold GAD (fulfilling three out of four GAD criteria) in young women together with data on co-morbidity and psychosocial functioning. The prevalence of clinically relevant worry and its predictive validity for the diagnosis of GAD were also examined.
METHOD: Young women (N = 2064), aged between 18 and 25, from a representative German community sample were diagnosed with a structured clinical interview (ADIS-L, German research version). An additional interview questioned all the participants about the frequency/intensity and uncontrollability of diverse worry topics.
RESULTS: Thirty-seven participants (1.8%) fulfilled the criteria of current GAD (1 week point prevalence) and 56 received a lifetime diagnosis (2.7%); a further 50 participants (2.3%) were diagnosed with sub-threshold GAD. Co-morbidity between GAD and other disorders was high for current (68%) and lifetime GAD (91%). GAD, as well as sub-threshold GAD, showed clearly reduced levels of psychosocial functioning. Whereas worries of low intensity and high controllability were ubiquitous in all subsamples, clinically defined worrying was rarely present in healthy subjects (0.89%) and of adequate predictive accuracy for GAD.
CONCLUSIONS: Full GAD and sub-threshold GAD were moderately frequent in young women. Although DSM-IV worry criteria proved to be highly useful, the strictness of the complete GAD-criteria should not lead to absence of attention from subclinical generalized anxiety states in research and practice.

Entities:  

Mesh:

Year:  2002        PMID: 12420892     DOI: 10.1017/s0033291702006360

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  10 in total

Review 1.  Constructive and unconstructive repetitive thought.

Authors:  Edward R Watkins
Journal:  Psychol Bull       Date:  2008-03       Impact factor: 17.737

2.  Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication.

Authors:  Ayelet Meron Ruscio; Michael Lane; Peter Roy-Byrne; Paul E Stang; Dan J Stein; Hans-Ulrich Wittchen; Ronald C Kessler
Journal:  Psychol Med       Date:  2005-12       Impact factor: 7.723

3.  Evidence for Transdiagnostic Repetitive Negative Thinking and Its Association with Rumination, Worry, and Depression and Anxiety Symptoms: A Commonality Analysis.

Authors:  Daniel E Gustavson; Alta du Pont; Mark A Whisman; Akira Miyake
Journal:  Collabra Psychol       Date:  2018-05-17

4.  Threshold and subthreshold generalized anxiety disorder among US adolescents: prevalence, sociodemographic, and clinical characteristics.

Authors:  M Burstein; K Beesdo-Baum; J-P He; K R Merikangas
Journal:  Psychol Med       Date:  2014-01-02       Impact factor: 7.723

5.  Understanding the relationships between health outcomes in generalized anxiety disorder clinical trials.

Authors:  Kathleen W Wyrwich; Neesha Harnam; Julie C Locklear; Henrik Svedsäter; Dennis A Revicki
Journal:  Qual Life Res       Date:  2010-08-31       Impact factor: 4.147

6.  Heterogeneity Matters: Predicting Self-Esteem in Online Interventions Based on Ecological Momentary Assessment Data.

Authors:  Vincent Bremer; Burkhardt Funk; Heleen Riper
Journal:  Depress Res Treat       Date:  2019-01-13

7.  Depressive Rumination and Co-Morbidity: Evidence for Brooding as a Transdiagnostic Process.

Authors:  Edward R Watkins
Journal:  J Ration Emot Cogn Behav Ther       Date:  2009-08-07

8.  Is worry different from rumination? Yes, it is more predictive of psychopathology!

Authors:  Jürgen Hoyer; Andrew T Gloster; Philipp Yorck Herzberg
Journal:  Psychosoc Med       Date:  2009-11-05

Review 9.  The prevalence and burden of subthreshold generalized anxiety disorder: a systematic review.

Authors:  Heidemarie Haller; Holger Cramer; Romy Lauche; Florian Gass; Gustav J Dobos
Journal:  BMC Psychiatry       Date:  2014-05-01       Impact factor: 3.630

10.  How to customize a bona fide psychotherapy for generalized anxiety disorder? A two-arms, patient blinded, ABAB crossed-therapist randomized clinical implementation trial design [IMPLEMENT 2.0].

Authors:  Christoph Flückiger; Christine Wolfer; Judith Held; Peter Hilpert; Julian Rubel; Mathias Allemand; Richard E Zinbarg; Andreea Vîslă
Journal:  BMC Psychiatry       Date:  2018-04-03       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.